SonoThera
Develops ultrasound-mediated nonviral genetic medicines
$125MSeries B
Role not disclosedIV
Illumina Ventures
illuminaventures.com ↗Activity from announced rounds
Activity in this selectionSeries B
Illumina Ventures invests in genomics and precision health, supporting companies that turn biological research into products and services.
Investment focus
The firm describes its role as building an ecosystem around advances in human health. Its published portfolio spans therapeutic development, enabling research technologies and biological applications.
Activity recorded by RoundOS
RoundOS examples include Encoded Therapeutics’ gene-regulation medicines, SonoThera’s gene-delivery platform and Syntax Bio’s cell-therapy technology. Robigo adds biological crop protection to the recorded activity. These are selected financings in the database, not an exhaustive portfolio.
Sources
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $125M 1 disclosed · full round size, not this investor’s share